Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
ANDAMAN: Twice-Daily Aspirin in Diabetic ACS
NCT02520921Phase 4Completed
- Sponsor
- Assistance publique - Hôpitaux de Paris
- Start
- Jun 2016
- Primary completion
- Jul 2024
- Modality
- Orthosteric Ligands
- Countries
- 1
01
Overview
A Phase 4 trial of aspirin in acute coronary syndrome (ACS), sponsored by Assistance publique - Hôpitaux de Paris. Started Jun 2016; status: completed.
02
Drugs
aspirin
03
Conditions
acute coronary syndrome (ACS)
Beyond the preview
Go deeper on NCT02520921.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02520921.